KPV peptide
Selected indexed studies
- Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. (J Pharm Sci, 2017) [PMID:28343991]
- Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. (Tissue Cell, 2025) [PMID:40073467]
- Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. (N Engl J Med, 2022) [PMID:35830641]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. (2017) pubmed
- Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. (2025) pubmed
- Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. (2022) pubmed
- Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination between Chronic and Acute Ulcerative Colitis. (2017) pubmed
- KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy. (2024) pubmed
- A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon. (2022) pubmed
- NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development. (2026) pubmed
- Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. (2010) pubmed
- Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. (2003) pubmed
- Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. (2017) pubmed